<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">869810</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2022.869810</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Effects of <italic>Pereskia aculeate</italic> Miller Petroleum Ether Extract on Complete Freund&#x2019;s Adjuvant-Induced Rheumatoid Arthritis in Rats and its Potential Molecular Mechanisms</article-title>
<alt-title alt-title-type="left-running-head">Chen et al.</alt-title>
<alt-title alt-title-type="right-running-head">Effects of PEEP on RA</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Yifei</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1664018/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Kaifei</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1663799/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Qin</surname>
<given-names>Yingyuan</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Suyi</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Guan</surname>
<given-names>Guokai</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huang</surname>
<given-names>Yao</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Chen</surname>
<given-names>Yu</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Mo</surname>
<given-names>Zhixian</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
</contrib>
</contrib-group>
<aff id="aff1">
<label>
<sup>1</sup>
</label>
<institution>School of Traditional Chinese Medicine</institution>, <institution>Southern Medical University</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<label>
<sup>2</sup>
</label>
<institution>School of Pharmacy</institution>, <institution>Guilin Medical University</institution>, <addr-line>Guilin</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<label>
<sup>3</sup>
</label>
<institution>Nephrology</institution>, <institution>Guilin TCM Hospital of China</institution>, <addr-line>Guilin</addr-line>, <country>China</country>
</aff>
<author-notes>
<corresp id="c001">&#x2a;Correspondence: Yu Chen, <email>624657305@qq.com</email>; Zhixian Mo, <email>cherrymo@smu.edu.cn</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Inflammation Pharmacology, a section of the journal Frontiers in Pharmacology</p>
</fn>
<fn fn-type="equal" id="fn1">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this work and share first authorship.</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/561129/overview">Tao Xu</ext-link>, Anhui Medical University, China</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1670060/overview">Jia-Xin Shi</ext-link>, The First People&#x2019;s Hospital of Lianyungang, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1289061/overview">Solomon Umukoro</ext-link>, University of Ibadan, Nigeria</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>09</day>
<month>05</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>869810</elocation-id>
<history>
<date date-type="received">
<day>05</day>
<month>02</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>04</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Chen, Liu, Qin, Chen, Guan, Huang, Chen and Mo.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Chen, Liu, Qin, Chen, Guan, Huang, Chen and Mo</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>
<bold>Objective:</bold> To investigate the therapeutic effect of petroleum ether extract of <italic>P. aculeate</italic> Miller (PEEP) on rheumatoid arthritis (RA).</p>
<p>
<bold>Methods:</bold> <italic>In vitro</italic>: The Cell Counting Kit-8 (CCK-8) was used to detect cell activity and select the optimal concentration of the extract; the effective site was screened by nitric oxide (NO) colorimetric method and Q-PCR method; the expression of p38, p-p38, p-MK2, and Tristetraprolin (TTP) in RAW 264.7 cells were detected by Western blot. <italic>In vivo</italic>: The rat model was established by complete Freund&#x2019;s adjuvant (CFA). The different doses of PEEP on CFA rats were observed with life status, paw swelling, spleen index, X-ray, Hematoxylin eosin (HE) staining; the secretion of Tumor necrosis factor &#x3b1; (TNF-&#x3b1;), interleukin-6 (IL-6) and Prostaglandin E2 (PGE<sub>2</sub>) were detected by Enzyme linked immunosorbent assay (ELISA); the expressions of p38, p-p38, p-MK2, and TTP in the ankle joints of CFA rats were detected by Western blot.</p>
<p>
<bold>Result:</bold> <italic>In vitro</italic>: PEEP, Ethyl Acetate Extract of <italic>P.</italic> acul<italic>eate</italic> Miller (EEEP), N-butanol Extract of <italic>P. aculeate</italic> Miller (BEEP) have no toxic effects on RAW264.7 macrophages. PEEP, EEEP, and BEEP reduce the secretion of NO in RAW264.7 cells induced by lipopolysaccharide (LPS), only PEEP significantly inhibited the mRNA expression levels of inflammatory factors TNF-&#x3b1; and IL-6; PEEP-dependently reduce the secretion of TNF-&#x3b1; and IL-6, decrease the expression of p-p38 and p-MK2, and the level of TTP phosphorylation in LPS-induced RAW264.7 cells. <italic>In vivo</italic>: PEEP improve the living conditions of CFA rats, reduce foot swelling, spleen index, bone surface erosion and joint space narrowing; reduce the formation of synovial cells, inflammatory cells and pannus in the foot and ankle joints. PEEP reduce the secretion of TNF-&#x3b1;, IL-6, PGE<sub>2</sub> in rat serum, downregulate the expression of p-p38 and p-MK2 in the ankle joint, and reduce the phosphorylation of TTP.</p>
<p>
<bold>Conclusion:</bold> PEEP improve the living conditions of CFA rats, reduce the degree of foot swelling, protect immune organs, reduce inflammatory cell infiltration, cartilage damage, pannus formation, reduce inflammation and RA damage. The mechanism through regulating the signal pathway of p38 mitogen-activated protein kinase (p38/MAPK), which reduces the release of TNF-&#x3b1;, IL-6, and PGE<sub>2</sub> in the serum.</p>
</abstract>
<kwd-group>
<kwd>petroleum ether extract of <italic>P. aculeate</italic> Miller</kwd>
<kwd>rheumatoid arthritis</kwd>
<kwd>p38/MAPK signaling pathway</kwd>
<kwd>inflammation</kwd>
<kwd>ethnomedicine</kwd>
</kwd-group>
<contract-num rid="cn001">82160832 81873030 81673628</contract-num>
<contract-num rid="cn002">2017GXNSFAA198255 2018GXNSFBA138028</contract-num>
<contract-sponsor id="cn001">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content>
</contract-sponsor>
<contract-sponsor id="cn002">Natural Science Foundation of Guangxi Zhuang Autonomous Region<named-content content-type="fundref-id">10.13039/100012547</named-content>
</contract-sponsor>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Rheumatoid arthritis is an autoimmune disease characterized by polyarthritis, progressive joint damage, and swelling deformities (<xref ref-type="bibr" rid="B31">Pu et al., 2016</xref>; <xref ref-type="bibr" rid="B39">Sparks, 2019</xref>; <xref ref-type="bibr" rid="B37">Shi et al., 2020</xref>). The pathological features of RA are joint synovial lesions, including excessive synovial cell proliferation, inflammatory cell infiltration, pannus formation, joint bone and cartilage destruction (<xref ref-type="bibr" rid="B4">Aletaha et al., 2011</xref>; <xref ref-type="bibr" rid="B51">Xing et al., 2018</xref>). According to relevant investigations and studies, the incidence of this disease worldwide is as high as 1%&#x2013;2%. There are more than 5 million RA patients in China, most of whom are in the 30&#x2013;50&#xa0;years old age group. It is the second largest cause of disability in the Chinese population (<xref ref-type="bibr" rid="B48">van der Woude and van der Helm-van Mil, 2018</xref>). It can quickly develop into multi-system inflammation and irreversible joint damage, leading to a decline in quality of life, disability and death without proper treatment (<xref ref-type="bibr" rid="B20">Malmstrom et al., 2017</xref>). Because the etiology and pathogenesis of RA are not clearly understood (<xref ref-type="bibr" rid="B23">Mcinnes and Schett, 2011</xref>). The targets and methods of clinical treatment are not clear, which brings certain difficulties to treatment. There are no highly targeted therapeutic drugs in clinical practice, the treatment of RA still from the aspects of analgesia, anti-inflammatory, preventing or reduce joint deformation and damage and increasing joint mobility (<xref ref-type="bibr" rid="B56">Yuan et al., 2015</xref>; <xref ref-type="bibr" rid="B36">Shams et al., 2021</xref>). These drugs reduce joint inflammation, inhibit the development of lesions and irreversible bone destruction, but long-term use of these drugs lead to immune system decline, bone marrow suppression, liver and kidney function damage, gastrointestinal function decline, cartilage degeneration, infection (<xref ref-type="bibr" rid="B1">Abbasi et al., 2019</xref>; <xref ref-type="bibr" rid="B18">Koller et al., 2019</xref>). Therefore, it is clinically necessary to find effective drugs with low toxicity to treat RA. In recent years, ethnomedicine and some natural medicine products have attracted more and more researchers&#x2019; attention because of their unique safe and effective pharmacological activities (<xref ref-type="bibr" rid="B13">Jang et al., 2014</xref>). Ethnomedicine can be a new resource for the treatment of rheumatoid arthritis with more and more evidences.</p>
<p>
<italic>P. aculeata</italic> Mill is a plant of the genus Pereskia in the Cactaceae family, also known as leaf cactus and tiger thorn. It is mainly produced in Yunnan, Guangdong, Guangxi and other regions south of the Yangtze River. It has a long history of folk medicine, with low side effects, and anti-inflammatory, antioxidant, antibacterial and other pharmacological activities (<xref ref-type="bibr" rid="B43">Tan et al., 2005</xref>; <xref ref-type="bibr" rid="B16">Kazama et al., 2012</xref>; <xref ref-type="bibr" rid="B30">Pinto and Scio, 2014</xref>; <xref ref-type="bibr" rid="B29">Pinto et al., 2015</xref>). Its medicinal liquor can treat bruises and rib pain. According to reports in the literature, there are as many as 30 chemical components in the essential oil of <italic>P. aculeata</italic> Mill leaves, among which the higher content includes phytol, palmitic acid, linoleic acid (<xref ref-type="bibr" rid="B38">Souza et al., 2014</xref>). In addition, the plant essential oil has the highest content of oxidized sesquiterpenes (44.92%), acorus spirenone comes next. The current research on the pharmacological effects of <italic>P. aculeata</italic> Mill mainly focuses on analgesia, cardiovascular protection and other related aspects. There are few studies on its anti-RA effect (<xref ref-type="bibr" rid="B28">Peng et al., 2018</xref>). The previous research show that <italic>P. aculeata</italic> Mill ethanol extract inhibited acetic acid-induced increase in vascular permeability and writhing behavior of mice in acetic acid-induced writhing reaction experiment, reduce the swelling of the feet of CFA rats and the level of IL-6 and other inflammatory cytokines in the rat serum, inhibit LPS-induced inflammatory response in RAW264.7 macrophages (<xref ref-type="bibr" rid="B15">Kanno et al., 2006</xref>).</p>
<p>This study aimed to screen effective sites by establishing an LPS-induced RAW264.7 macrophage inflammation model, and through the FCA rat model to evaluate the therapeutic effect and possible mechanism of PEEP, provide a more adequate theoretical basis for the development and utilization of PEEP.</p>
</sec>
<sec id="s2">
<title>2 Materials and Methods</title>
<sec id="s2-1">
<title>2.1 Cell Culture and Laboratory Animals</title>
<p>Mouse macrophages RAW264.7 were from the Pharmacology Laboratory of Guilin Medical University, China, and were preserved by our laboratory for future generations.</p>
<p>Healthy female SD rats, SPF grade, 60 rats, weight (200 &#xb1; 20&#xa0;g), provided by Hunan SJA Laboratory Animal Co., Ltd., license SCXK Xiang 2016-0002. Rats were kept at a temperature of 21&#xb0;C&#x2013;25&#xb0;C and a relative humidity of 50%&#x2013;60%. Rats in each group eat and drink freely.</p>
</sec>
<sec id="s2-2">
<title>2.2 Main Experimental Reagents</title>
<sec id="s2-2-1">
<title>2.2.1 Main Drugs and Reagents</title>
<p>
<italic>P. aculeata</italic> Mill petroleum ether extract; NO kit (Wuhan, Elabscience Biotechnology Co., Ltd.); p38MAPK antibody, p-p38MAPK antibody, p-MK2 antibody and TTP antibody (CST, Miami, FL, United States); &#x3b2;-Actin (Proteintech company, Chicago, IL, United States); Primary antibody and secondary antibody diluent (China, Beyotime Biotechnology); Rainbow marker (Thermo Fisher Scientific, Waltham, MA, United States); Fetal Bovine Serum (GIBCO Company, Waltham, MA, United States); Cell protein lysate, Phosphatase inhibitor (Beijing, CWBIO Biotechnology Co., Ltd.); Lipopolysaccharide (Sigma-Aldrich Reagent Company, United States); CCK-8 kit (Japan, DOJIDO company); AceQ qPCR Green Master Mix, HiScript QRT SuperMIX (Nanjing, Vazyme Biotech Co., Ltd.); 1M Tirs-Hcl 6.8, 1M Tirs-Hcl 8.8, PBS (Phosphate buffer asline), Glycine, SDS, Tris (China, Solarbio Biotechnology Co., Ltd.); Primer (Shenzhen, BGI Technology Co., Ltd.). PEEP (Laboratory Preparation); Freund&#x2019;s complete adjuvant (SIGMA-ALDRICH, St. Louis, MI, United States); Dexamethasone (DEX) (Guangdong, Sancai Shiqi Pharmaceutical Co., Ltd.); Rat PGE<sub>2</sub>, IL-6 and TNF-&#x3b1; kits (Wuhan, Elabscience Biotechnology Co., Ltd.); 4% tissue fixative (China, Solarbio Life Sciences Co., Ltd.) (<xref ref-type="table" rid="T1">Tables 1</xref>, <xref ref-type="table" rid="T2">2</xref>).</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Primer names and sequences.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Primer name</th>
<th align="center">Primer sequence</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">GAPDH-F</td>
<td align="center">5&#x2032;-AGA&#x200b;AGG&#x200b;CTG&#x200b;GGG&#x200b;CTC&#x200b;ATT&#x200b;TG-3&#x2032;</td>
</tr>
<tr>
<td align="left">GAPDH-R</td>
<td align="center">5&#x2032;-AGG&#x200b;GGC&#x200b;CAT&#x200b;CCA&#x200b;CAG&#x200b;TCT&#x200b;TC-3&#x2032;</td>
</tr>
<tr>
<td align="left">IL-6-F</td>
<td align="center">5&#x2032;-CCG&#x200b;GAG&#x200b;AGG&#x200b;AGA&#x200b;CTT&#x200b;CAC&#x200b;AG-3&#x2032;</td>
</tr>
<tr>
<td align="left">IL-6-R</td>
<td align="center">5&#x2032;-TCC&#x200b;ACG&#x200b;ATT&#x200b;TCC&#x200b;CAG&#x200b;AGA&#x200b;AC-3&#x2032;</td>
</tr>
<tr>
<td align="left">TNF-&#x3b1;-F</td>
<td align="center">5&#x2032;-CGT&#x200b;CAG&#x200b;CCG&#x200b;ATT&#x200b;TGC&#x200b;TAT&#x200b;CT-3&#x2032;</td>
</tr>
<tr>
<td align="left">TNF-&#x3b1;-R</td>
<td align="center">5&#x2032;-CGG&#x200b;ACT&#x200b;CCG&#x200b;CAA&#x200b;AGT&#x200b;CTA&#x200b;AG-3&#x2032;</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Q-PCR reaction system.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Reaction system</th>
<th align="center">Volume (&#x3bc;l)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">SYBR</td>
<td align="center">5</td>
</tr>
<tr>
<td align="left">Forward primer</td>
<td align="center">1</td>
</tr>
<tr>
<td align="left">Reverse primer</td>
<td align="center">1</td>
</tr>
<tr>
<td align="left">cDNA</td>
<td align="center">1</td>
</tr>
<tr>
<td align="left">ddH2O</td>
<td align="center">2</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
</sec>
<sec id="s2-2-3">
<title>2.3 Main Experimental Equipment</title>
<p>Epoch microplate reader (Biotek, Winooski, VT, United States); Small desktop refrigerated centrifuge, Liquid nitrogen storage tank (Thermo Fisher Scientific, Waltham, MA, United States); Protein electrophoresis, Electric transfer system, Gel imaging analysis system (Bio-Rad, Hercules, CA, United States); Constant temperature water bath (Shanghai, Baoling Instrument Equipment Co., Ltd.); Carbon dioxide constant temperature incubator, Ice machine (Sanyo, Japan); Ultra-clean workbench, High Pressure Steam Sterilizer (Shandong, BIOBASE); Fluorescence quantitative PCR machine (IT-IS company, United Kingdom); Foot swelling degree measuring instrument (Ugo Basile company, Italy); Small animal live optical imaging system (Shanghai, PerkinElmer Enterprise Management Co., Ltd.); Pipette gun (Eppendorf, Germany); Electric heating constant temperature sink (Shanghai, Huitai Instrument Manufacturing Co., Ltd.).</p>
</sec>
<sec id="s2-4">
<title>2.4 Experimental Method</title>
<sec id="s2-4-1">
<title>2.4.1 Preparation of Effective Parts of <italic>P. aculeata</italic> Mill</title>
<p>We took 1,000&#xa0;ml of <italic>P. aculeata</italic> Mill ethanol extract, filtered with a qualitative filter paper circle, and then concentrated it with a rotary evaporator, added water to suspend the extract. Extract with petroleum ether, ethyl acetate and n-butanol, recover the solvent and evaporate to dryness to obtain PEEP 2.415&#xa0;g, EEEP 3.598&#xa0;g and BEEP 3.473&#xa0;g.</p>
</sec>
<sec id="s2-4-2">
<title>2.4.2 Screening of Effective Parts of <italic>P. aculeata</italic> Mill</title>
<p>RAW264.7 macrophages were used to screen the effective site of <italic>P. aculeata</italic> Mill. The concentration of each extraction part of <italic>P. aculeata</italic> Mill is setting as follows: PEEP: 0, 15, 30, 60, 120, and 240&#xa0;&#x3bc;g/ml; EEEP: 0, 5, 15, 30, and 60&#xa0;&#x3bc;g/ml, BEEP: 0, 10, 20, 40, and 80&#xa0;&#x3bc;g/ml. The effects of PEEP, EEEP, and BEEP on the viability of RAW264.7 macrophages were detected by CCK-8, calculate the survival rate of each group of cells according to the formula.</p>
<p>The experiment set up normal group, LPS group (1&#xa0;&#x3bc;g/ml), LPS &#x2b; DEX group (1 &#xd7; 10<sup>&#x2212;4</sup>&#xa0;M), LPS &#x2b; PEEP (60&#xa0;&#x3bc;g/ml), LPS &#x2b; EEEP (30&#xa0;&#x3bc;g/ml), LPS &#x2b; BEEP (40&#xa0;&#x3bc;g/ml). The effect of each extract part on NO content in RAW264.7 macrophages stimulated by LPS was detected according to the instructions in Wuhan Elabscience Biotechnology Co., Ltd. NO kit, and Q-PCR was used to detect the levels of TNF-&#x3b1; and IL-6 in RAW264.7 macrophages stimulated by LPS in each extraction site to screen the most effective site.</p>
<list list-type="simple">
<list-item>
<p>(1) The configuration of the Q-PCR reaction system:</p>
</list-item>
<list-item>
<p>(2) The relative expression formula of the target gene is:</p>
</list-item>
</list>
<disp-formula id="equ2">
<mml:math id="m1">
<mml:mrow>
<mml:msup>
<mml:mrow>
<mml:mrow>
<mml:mo>[</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mrow>
<mml:msup>
<mml:mn>2</mml:mn>
<mml:mrow>
<mml:mi mathvariant="normal">C</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mtext>target</mml:mtext>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mtext>gene</mml:mtext>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:msup>
</mml:mrow>
<mml:mo>/</mml:mo>
<mml:mrow>
<mml:msup>
<mml:mn>2</mml:mn>
<mml:mrow>
<mml:mi mathvariant="normal">C</mml:mi>
<mml:mi>t</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mtext>reference</mml:mtext>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mtext>gene</mml:mtext>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:msup>
</mml:mrow>
</mml:mrow>
</mml:mrow>
<mml:mo>]</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msup>
<mml:mo>&#x3d;</mml:mo>
<mml:msup>
<mml:mn>2</mml:mn>
<mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:mi mathvariant="normal">&#x394;</mml:mi>
<mml:mi mathvariant="normal">C</mml:mi>
<mml:mi mathvariant="normal">t</mml:mi>
</mml:mrow>
</mml:msup>
</mml:mrow>
</mml:math>
</disp-formula>
<p>According to the previous experimental results, the effect of PEEP (15, 30, and 60&#xa0;&#x3bc;g/ml) on NO content in RAW264.7 macrophages stimulated by LPS was detected. Q-PCR was used to detect the effect of PEEP (15, 30 and 60&#xa0;&#x3bc;g/ml) on the expression levels of TNF-&#x3b1; and IL-6 in LPS-induced RAW264.7 macrophages. And the effect of PEEP (15, 30 and 60&#xa0;&#x3bc;g/ml) on p38/MAPK signaling pathway in LPS-induced RAW264.7 macrophages was detected by western blot.</p>
</sec>
<sec id="s2-4-3">
<title>2.4.3 Preparation and Grouping of CFA Rat Model</title>
<p>After adaptive feeding for 7&#xa0;days, 60 rats were randomly divided into six groups: blank group, model group, L-PEEP (16&#xa0;mg/kg) group, M-PEEP (32&#xa0;mg/kg) group, H-PEEP (64&#xa0;mg/kg) group, DEX (0.5&#xa0;mg/kg) group. Except for the 6 rats in the blank group, the rats in the other groups all used Freund&#x2019;s complete adjuvant to prepare CFA models. After routine disinfection, straighten the right paw of the rat, and use a 1&#xa0;ml sterile syringe to inject 0.1&#xa0;ml of Freund&#x2019;s complete adjuvant into the center of the plantar of each rat.</p>
</sec>
<sec id="s2-4-4">
<title>2.4.4 Method of Administration</title>
<p>According to the characteristics of the CFA model (<xref ref-type="bibr" rid="B7">Chang et al., 2011</xref>), the foot swelling at the model site reached its peak (acute inflammatory response) at 18&#x2013;27&#xa0;h, and it continued for 10&#xa0;days and then gradually reduced; secondary lesions generally appeared at 11&#xa0;days after inflammation. Combined with pre-experimental results, in this experiment, the drug was started 14&#xa0;days after the model was established, and the drug was administered continuously for 10&#xa0;days.</p>
</sec>
<sec id="s2-4-5">
<title>2.4.5 Measurement of Rat Foot Swelling Degree</title>
<p>Observe each group at 0, 9, 18, and 27&#xa0;h, d 3, d 5, d 9, d 11, d 13, d 15, d 18, d 20, d 22, and d 24 after inflammation. The swelling of the hind paw of the rat was measured, and the swelling degree of the right hind paw and the swelling degree of the left hind paw on the non-inflammatory side were measured with a foot swelling meter.</p>
</sec>
<sec id="s2-4-6">
<title>2.4.6 X-Rays to Observe Changes in Cartilage and Bone Structure</title>
<p>After 10&#xa0;days of administration, the rats in each group were observed to undergo changes in cartilage and bone structure by X-ray. The rats in each group were intraperitoneally injected with 10% chloral hydrate. After anesthesia, take the supine position and transfer to the small animal <italic>in vivo</italic> imaging device, and take pictures of the left and right feet of each group of rats in turn.</p>
</sec>
<sec id="s2-4-7">
<title>2.4.7 Determination of Spleen Index</title>
<p>After the rats were sacrificed, the abdominal cavity of the rats was cut open quickly and the spleens were cut out. The spleens were quickly rinsed with cold PBS, and the remaining liquid was soaked up with filter paper and weighed to calculate the spleen index of the rats.<disp-formula id="equ1">
<mml:math id="m2">
<mml:mrow>
<mml:mtext>Spleen</mml:mtext>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mtext>index</mml:mtext>
<mml:mo>&#x3d;</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mtext>spleen</mml:mtext>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mtext>weight</mml:mtext>
</mml:mrow>
<mml:mo>/</mml:mo>
<mml:mrow>
<mml:mtext>corresponding</mml:mtext>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mtext>rat&#x27;s</mml:mtext>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mtext>weight</mml:mtext>
</mml:mrow>
</mml:mrow>
</mml:mrow>
</mml:math>
</disp-formula>
</p>
</sec>
<sec id="s2-4-8">
<title>2.4.8 Determination of Serum TNF-&#x3b1;, IL-6, and PGE<sub>2</sub> Levels in Rats</title>
<p>After the last administration, the rats were fasted for 24&#xa0;h. After weighing, the rats in each group were blood collected from the vein behind the eyeball and centrifuged to extract serum. They were allowed to stand in a refrigerator at 4&#xb0;C for 2&#xa0;h, centrifuged at 4,000&#xa0;rpm for 10&#xa0;min, and the supernatant was collected and used for experiment. The concentration of TNF-&#x3b1;, IL-6, and PGE<sub>2</sub> in serum was detected by ELISA method, and the operation was performed according to the kit instructions.</p>
</sec>
<sec id="s2-4-9">
<title>2.4.9 HE Staining to Observe the Pathological Changes of the Foot and Ankle Joints</title>
<p>After removing the soft tissue around the right hind ankle of the rat, it was immersed in 4% tissue fixative for 24&#xa0;h, and sent to the Department of Pathology, Affiliated Hospital of Guilin Medical College to make HE stained sections. The slices were taken to capture images under a 200&#xd7;, 400&#xd7; field of view.</p>
</sec>
<sec id="s2-4-10">
<title>2.4.10 Western Blot Detection</title>
<p>Total protein extracted from cells and ankle joints, and then separated by SDS-PAGE gel electrophoresis to bromophenol blue to the bottom of the separation gel. The protein was transferred to PVDF membrane and blocked with 5% skimmed milk powder for 1.5&#xa0;h. Incubate overnight with primary antibodies &#x3b2;-actin, p38, p-p38, p-MK2, and TTP at 4&#xb0;C. Incubate for 1.5&#xa0;h with goat anti-mouse IgG and goat anti-rabbit IgG. All experiments were repeated 3 times.</p>
</sec>
</sec>
<sec id="s2-5">
<title>2.5 Statistical Analysis</title>
<p>SPSS 20.0 was used for data analysis, GraphPad Prism 6.0 was used for graphing, and the data were expressed as mean &#xb1; standard deviation (mean &#xb1; S.E.M). The comparison between groups was performed by one-way analysis of variance. <italic>p</italic> &#x3c; 0.05 and <italic>p</italic> &#x3c; 0.01 were considered statistically different.</p>
</sec>
</sec>
<sec id="s3">
<title>3 Results</title>
<sec id="s3-1">
<title>3.1 CCK-8 Detects the Effect of Each Extraction Part of <italic>P. aculeata</italic> Mill on the Viability of RAW264.7 Macrophages</title>
<p>The CCK-8 experiment was used to detect the effects of PEEP, EEEP, and BEEP on the survival rate of RAW264.7 macrophages. PEEP (0, 15, 30, and 60&#xa0;&#x3bc;g/ml), EEEP (0, 5, 15, and 30&#xa0;&#x3bc;g/ml) and BEEP (0, 10, 20, and 40&#xa0;&#x3bc;g/ml) concentration survival rate is similar to the blank control group (<xref ref-type="fig" rid="F1">Figures 1A&#x2013;C</xref>). The results illustrated that each extraction site has no toxic and side effects on RAW264.7 macrophages within the designed concentration. Therefore, PEEP (60&#xa0;&#x3bc;g/ml), EEEP (30&#xa0;&#x3bc;g/ml), and BEEP (40&#xa0;&#x3bc;g/ml) were selected as the highest concentrations for subsequent experiments.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Effects of different concentrations of PEEP, EEEP, and BEEP on cell viability in RAW264.7 cells. Results were exhibited as the means &#xb1; S.E.M. of three independent experiments. <sup>&#x2a;</sup>
<italic>p</italic> &#x3c; 0.05, <sup>&#x2a;&#x2a;</sup>
<italic>p</italic> &#x3c; 0.01 vs. Normal group.</p>
</caption>
<graphic xlink:href="fphar-13-869810-g001.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>3.2 The Effect of the Extracts of <italic>P. aculeata</italic> Mill on the Expression of Nitric Oxide in RAW264.7 Macrophages Induced by Lipopolysaccharide</title>
<p>LPS stimulate macrophages to express nitric oxide synthase (iNOS) and release NO (<xref ref-type="bibr" rid="B9">Chen et al., 2014</xref>). Therefore, the effect of each extraction site of <italic>P. aculeata</italic> Mill on LPS-induced NO expression in RAW264.7 macrophages was investigated by NO colorimetry. The expression level of No in RAW264.7 macrophages induced by LPS was significantly reduced (<italic>p</italic> &#x3c; 0.01) through the intervention of each extraction site of <italic>P. aculeata</italic> Mill (<xref ref-type="fig" rid="F2">Figure 2A</xref>). The inhibitory effect of PEEP on NO is stronger than other parts, and it has the most significant anti-inflammatory potential. PEEP (15, 30 and 60&#xa0;&#x3bc;g/ml) significantly reduce the expression of NO in RAW264.7 macrophages induced by LPS when compared with the model group, and in concentration-dependent (<xref ref-type="fig" rid="F2">Figure 2B</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Effects of different concentrations of PEEP, EEEP and BEEP on cell viability in RAW264.7 macrophages. <bold>(A)</bold> Effect of PEEP (60&#xa0;&#x3bc;g/ml), EEEP (30&#xa0;&#x3bc;g/ml) and BEEP (40&#xa0;&#x3bc;g/ml) on the content of NO induced by LPS in RAW264.7 macrophages. <bold>(B)</bold> Effect of PEEP (15, 30 and 60&#xa0;&#x3bc;g/ml) on the content of NO induced by LPS in RAW264.7 macrophages. Results were exhibited as the means &#xb1; S.E.M. of three independent experiments. <sup>&#x23;&#x23;</sup>
<italic>p</italic> &#x3c; 0.01 vs. Normal; <sup>&#x2a;</sup>
<italic>p</italic> &#x3c; 0.05, <sup>&#x2a;&#x2a;</sup>
<italic>p</italic> &#x3c;0.01 vs. LPS group.</p>
</caption>
<graphic xlink:href="fphar-13-869810-g002.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>3.3 Effects of the Extracts of <italic>P. aculeata</italic> Mill on the Expression of TNF-&#x3b1; and IL-6 in RAW264.7 Macrophages Induced by Lipopolysaccharide</title>
<p>Macrophages play an important role in the pathogenesis of RA by secreting TNF-&#x3b1;, IL-6 and other inflammatory cytokines (<xref ref-type="bibr" rid="B15">Kanno et al., 2006</xref>). The related expression results are shown in <xref ref-type="fig" rid="F3">Figures 3A,B</xref>. PEEP reduce the mRNA expression levels of TNF-&#x3b1; and IL-6 in RAW264.7 macrophages induced by LPS when compared with the model group (<italic>p</italic> &#x3c; 0.05, <italic>p</italic> &#x3c; 0.01). However, the inhibition of TNF-&#x3b1; and IL-6 by EEEP and BEEP was not statistically significant (<italic>p</italic> &#x3e; 0.05). PEEP (15, 30 and 60&#xa0;&#x3bc;g/ml) decreased the mRNA levels of TNF-&#x3b1; and IL-6 in LPS-induced RAW264.7 macrophages (<italic>p</italic> &#x3c; 0.05, <italic>p</italic> &#x3c; 0.01) in a concentration-dependent manner (<xref ref-type="fig" rid="F3">Figures 3C,D</xref>). The above results indicate that PEEP significantly reduce the level of TNF-&#x3b1; and IL-6 mRNA in activated RAW264.7 macrophages, and the concentration increases, the lower the mRNA level. Therefore, based on the experimental results, PEEP (15, 30 and 60&#xa0;&#x3bc;g/ml) was selected for subsequent experiments.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Effect of PEEP, EEEP and BEEP on the expressions of inflammatory factors in RAW264.7 macrophages induced by LPS. <bold>(A)</bold> The effect of PEEP (60&#xa0;&#x3bc;g/ml), EEEP (30&#xa0;&#x3bc;g/ml) or BEEP (40&#xa0;&#x3bc;g/ml) on mRNA expressions of TNF-&#x3b1; were detected using Q-PCR assays. <bold>(B)</bold> The effect of PEEP (60&#xa0;&#x3bc;g/ml), EEEP (30&#xa0;&#x3bc;g/ml) or BEEP (40&#xa0;&#x3bc;g/ml) on mRNA expressions of IL-6 were detected using Q-PCR assays. <bold>(C)</bold> The effect of PEEP (15, 30 and 60&#xa0;&#x3bc;g/ml) on mRNA expressions of TNF-&#x3b1; were detected using Q-PCR assays. <bold>(D)</bold> The effect of PEEP (15, 30 and 60&#xa0;&#x3bc;g/ml) on mRNA expressions of IL-6 were detected using Q-PCR assays. The data were expressed as the means &#xb1; S.E.M. of three independent experiments. <sup>&#x23;&#x23;</sup>
<italic>p</italic> &#x3c; 0.01 vs. Normal group; <sup>&#x2a;</sup>
<italic>p</italic> &#x3c; 0.05, <sup>&#x2a;&#x2a;</sup>
<italic>p</italic> &#x3c; 0.01 vs. LPS group.</p>
</caption>
<graphic xlink:href="fphar-13-869810-g003.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>3.4 Effect of PEEP on the p38/MAPK Signaling Pathway of Lipopolysaccharide-Induced RAW264.7 Macrophages</title>
<p>The p38/MAPK pathway is closely related to the regulation of inflammatory response. It is an important mediator involved in the expression of a variety of genes in the stress process. After activation, it moves from the cytoplasm to the nucleus, and interacts with the corresponding transcription factors to control the transcription of a variety of genes (<xref ref-type="bibr" rid="B33">Roussel et al., 2010</xref>), it plays a key role in the signal transduction of a variety of cytokine synthesis induced by LPS. Therefore, we analyzed the expression of p38, p-p38, p-MK2, and TTP protein in order to further explore the molecular mechanism of PEEP anti-inflammatory. PEEP downregulated the expression levels of p-p38, p-MK2 and increased the expression level of TTP in LPS-induced RAW264.7 macrophages when compared with the model group (<italic>p</italic> &#x3c; 0.01, <italic>p</italic> &#x3c; 0.05) in a concentration-dependent (<xref ref-type="fig" rid="F4">Figure 4</xref>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Effect of PEEP on p38, p-p38, p-MK2, and TTP expressions induced by LPS in RAW264.7 macrophages. <bold>(A)</bold> The protein expressions of p38, p-p38, p-MK2, and TTP were detected by using western blot analysis. <bold>(B)</bold> Quantitative analysis of gray value of p38 was performed in several groups with &#x3b2;-actin as loading control. <bold>(C)</bold> Quantitative analysis of gray value of p-p38 was performed in several groups with &#x3b2;-actin as loading control. <bold>(D)</bold> Quantitative analysis of gray value of p-MK2 was performed in several groups with &#x3b2;-actin as loading control. <bold>(E)</bold> Quantitative analysis of gray value of TTP was performed in several groups 27 with &#x3b2;-actin as loading control. Data represent the mean &#xb1; S.E.M. of three independent experiments. <sup>
<italic>&#x23;&#x23;</italic>
</sup>
<italic>p</italic> &#x3c; 0.01 vs. Normal group; <sup>&#x2a;</sup>
<italic>p</italic> &#x3c; 0.05, <sup>&#x2a;&#x2a;</sup>
<italic>p</italic> &#x3c; 0.01. vs. LPS group.</p>
</caption>
<graphic xlink:href="fphar-13-869810-g004.tif"/>
</fig>
</sec>
<sec id="s3-5">
<title>3.5 General Observation of Rats in Each Group</title>
<p>The rats with normal appetite and active behavior before CFA injection. The skin of the feet of CFA rats began to become red, and the modeled feet were swollen after inflammation for 2&#xa0;days. And the primary paws of CFA rats were significantly more swollen, and movement was significantly restricted, the secondary paws were not significantly swollen, and appetite decreased slightly after inflammation for 7&#xa0;days when compared with the control group. Rats in the PEEP medium and high dose group had better eating conditions, and relieved the swelling of the feet after 10&#xa0;days of administration when compared with the model group. No abnormally dead rats were found.</p>
</sec>
<sec id="s3-6">
<title>3.6 The Effect of PEEP on the Swelling Degree of Complete Freund&#x2019;s Adjuvant Rats&#x2019; Feet</title>
<p>Combined with the characteristics of the CFA model (<xref ref-type="bibr" rid="B7">Chang et al., 2011</xref>). The swelling degree of the right hind foot of the model group CFA rats gradually reached a peak after 15&#xa0;days of modeling when compared with the blank group (<italic>p</italic> &#x3c; 0.01). The swelling of the right hind foot of rats in the M-PEEP (32&#xa0;mg/kg) group and H-PEEP (64&#xa0;mg/kg) group decreased significantly after 10&#xa0;days of administration when compared with the model group (<italic>p</italic> &#x3c; 0.01). The CFA rats in the model group developed secondary swelling of the left hind foot 11&#xa0;days after modeling when compared with the blank group (<italic>p</italic> &#x3c; 0.01). The swelling of the left hind foot of the rats in the M-PEEP (32&#xa0;mg/kg) group and H-PEEP (64&#xa0;mg/kg) group decreased significantly after 10&#xa0;days of administration when compared with the model group (<italic>p</italic> &#x3c; 0.01). The results show that the petroleum ether site significantly reduce the degree of foot swelling in CFA model rats (<xref ref-type="fig" rid="F5">Figures 5A,B</xref>).</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Effects of different doses of PEEP on swelling of paw in CFA rats. <bold>(A)</bold>Effects of different doses of PEEP on swelling of right hind paw in CFA rats. <bold>(B)</bold> Effects of different doses of PEEP on swelling of left hind paw in CFA rats. <sup>&#x23;&#x23;</sup>
<italic>p</italic> &#x3c; 0.01 vs. Normal group; <sup>&#x2a;</sup>
<italic>p</italic> &#x3c; 0.05, <sup>&#x2a;&#x2a;</sup>
<italic>p</italic> &#x3c; 0.01 vs. CFA group.</p>
</caption>
<graphic xlink:href="fphar-13-869810-g005.tif"/>
</fig>
</sec>
<sec id="s3-7">
<title>3.7 The Effect of PEEP on the Spleen Index of Complete Freund&#x2019;s Adjuvant Rats</title>
<p>The results are presented in <xref ref-type="table" rid="T3">Table 3</xref>, the spleen index of the model group increased when compared with the blank group (<italic>p &#x3c;</italic> 0.05). The spleen index of M-PEEP (32&#xa0;mg/kg) group and H-PEEP (64&#xa0;mg/kg) group was significantly lower than model group (<italic>p &#x3c;</italic> 0.05). The spleen index of the L-PEEP (16&#xa0;mg/kg) group was lower than model group, but there is no significant difference (<italic>p</italic> &#x3e; 0.05).</p>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>The spleen index of CFA rats.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Group</th>
<th align="center">Dose (mg/kg)</th>
<th align="center">Spleen index (mg/kg)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Nor</td>
<td align="center">0</td>
<td align="char" char="plusmn">2.52 &#xb1; 0.11</td>
</tr>
<tr>
<td align="left">CFA</td>
<td align="center">0</td>
<td align="char" char="plusmn">2.99 &#xb1; 0.10<sup>&#x23;</sup>
</td>
</tr>
<tr>
<td align="left">DEX</td>
<td align="center">0.5</td>
<td align="char" char="plusmn">2.68 &#xb1; 0.07<sup>&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">L-PEEP</td>
<td align="center">16</td>
<td align="char" char="plusmn">2.95 &#xb1; 0.12</td>
</tr>
<tr>
<td align="left">M-PEEP</td>
<td align="center">32</td>
<td align="char" char="plusmn">2.67 &#xb1; 0.05<sup>&#x2a;</sup>
</td>
</tr>
<tr>
<td align="left">H-PEEP</td>
<td align="center">64</td>
<td align="char" char="plusmn">2.61 &#xb1; 0.09<sup>&#x2a;</sup>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="Tfn1">
<p>The data were expressed as the means &#xb1; S.E.M. (n &#x3d; 5).<sup>&#x23;</sup>
<italic>p</italic> &#x3c; 0.05 vs. Normal group. <xref ref-type="table-fn" rid="Tfn1">
<sup>&#x2a;</sup>
</xref>
<italic>p</italic> &#x3c; 0.05, vs. CFA, group.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3-8">
<title>3.8 Effect of PEEP on the Levels of IL-6, PGE<sub>2</sub> and TNF-&#x3b1; in Serum of Complete Freund&#x2019;s Adjuvant Rats</title>
<p>The serum levels of IL-6, PGE<sub>2</sub> and TNF-&#x3b1; in the model group increased significantly when compared with the blank group (<italic>p</italic> &#x3c; 0.01). The expressions of IL-6 and PGE<sub>2</sub> in the serum of rats in the L-PEEP (16&#xa0;mg/kg) group, M-PEEP (32&#xa0;mg/kg) group, and H-PEEP (64&#xa0;mg/kg) group were significantly lower than the model group (<italic>p &#x3c;</italic> 0.05). the expression of TNF-&#x3b1; in the serum of rats in the M-PEEP (32&#xa0;mg/kg) group and H-PEEP (64&#xa0;mg/kg) group was significantly reduced (<italic>p</italic> &#x3c; 0.05), but the L-PEEP (16&#xa0;mg/kg) group only had a decreasing trend, and the difference was not statistically significant (<italic>p</italic> &#x3e; 0.05). Therefore, it can be considered that medium and high doses of PEEP can reduce the expression of IL-6, PGE<sub>2</sub>, and TNF-&#x3b1;, which can inhibit inflammation and control the development of the disease. The treatment effect of L-PEEP group was slightly worse than that of M-PEEP group and H-PEEP group (<xref ref-type="fig" rid="F6">Figure 6</xref>).</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Effects of different doses of PEEP on the expression of inflammatory cytokines in CFA rat serum. <bold>(A)</bold> The concentrations of IL-6 in serum were determined by ELISA. <bold>(B)</bold> The concentrations of PGE2 in serum were determined by ELISA. <bold>(C)</bold> The concentrations of TNF-&#x3b1; in serum were determined by ELISA. The data were expressed as the means &#xb1; S.E.M. (<italic>n</italic> &#x3d; 5). <sup>&#x23;&#x23;</sup>
<italic>p</italic> &#x3c; 0.05 vs. Normal group; <sup>&#x2a;</sup>
<italic>p</italic> &#x3c; 0.05, <sup>&#x2a;&#x2a;</sup>
<italic>p</italic> &#x3c; 0.01 vs. CFA group.</p>
</caption>
<graphic xlink:href="fphar-13-869810-g006.tif"/>
</fig>
</sec>
<sec id="s3-9">
<title>3.9 X-Ray Observation Results of Rat Feet in Each Group</title>
<p>The paws of the rats in the model group were swollen, the joint space was narrow, and the articular surface was blurred. M-PEEP (32&#xa0;mg/kg) group, H-PEEP (64&#xa0;mg/kg) group and DEX group (0.5&#xa0;mg/kg) reduced the swelling of soft tissue around the ankle joint and improved the bone surface erosion in rats and joint space narrowing after 10&#xa0;days of administration by observing the X-ray of the right hind paw of the rats in each group. The left foot swelling of CFA rats in each group was not obvious, and there was no bone destruction (<xref ref-type="fig" rid="F7">Figure 7</xref>).</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>X-ray evaluation of joint injury in CFA rats. X-rays showed the effects of different doses of PEEP on hind paw and right paw of CFA rats. Blue arrow, swelling of soft tissue; yellow arrow, narrow joint space, blurred joint surface.</p>
</caption>
<graphic xlink:href="fphar-13-869810-g007.tif"/>
</fig>
</sec>
<sec id="s3-10">
<title>3.10 Observation of PEEP on HE Staining of Ankle Joint of Complete Freund&#x2019;s Adjuvant Rats</title>
<p>HE staining of the blank group showed complete and clear structure, no inflammatory cell infiltration and synovial hyperplasia, and no damage to cartilage and bone joints. Cartilage destruction, inflammatory cell infiltration, proliferation of a large number of synovial cells, and pannus formation occurred in the foot and ankle joints in the model group. HE staining in the DEX (0.5&#xa0;mg/kg) group showed slight synovial hyperplasia and less inflammatory cell infiltration when compared with the model group. The degree of synovial hyperplasia or inflammatory cell infiltration in the M-PEEP (32&#xa0;mg/kg) group and H-PEEP (64&#xa0;mg/kg) group was lighter, and the cartilage erosion was lighter than the model group (<xref ref-type="fig" rid="F8">Figure 8</xref>).</p>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>The pathologial slice pictures of the ankle joint of CFA rats treated with various doses of. PEEP. Red arrow, articular cartilage; black arrow, synovial hyperplasia; green arrow, inflammatory cell infiltration; blue arrow, pannus.</p>
</caption>
<graphic xlink:href="fphar-13-869810-g008.tif"/>
</fig>
</sec>
<sec id="s3-11">
<title>3.11 Effect of PEEP on p38/MAPK Signal Pathway in Complete Freund&#x2019;s Adjuvant Rats</title>
<p>The results are presented in <xref ref-type="fig" rid="F9">Figure 9</xref>, the expression of p38 in the ankle joint has no significant difference (<italic>p</italic> &#x3e; 0.05). The expression of p-p38 and p-MK2 in the M-PEEP (32&#xa0;mg/kg) group and the H-PEEP (64&#xa0;mg/kg) group was reduced when compared with the model group (<italic>p</italic> &#x3c; 0.01), while the expression of p-p38 and p-MK2 in the L-PEEP (16&#xa0;mg/kg) group has a decreasing trend, no significant difference (<italic>p</italic> &#x3e; 0.05). The protein expression of TTP in the ankle joints increased when compared with the model group (<italic>p</italic> &#x3c; 0.01). Overall, the results show that PEEP can inhibit the expression of p-p38 and p-MK2 proteins in the foot and ankle joints of CFA rats, and reduce the phosphorylation of TTP. There is a certain dose relationship, and the best effect is shown at high doses.</p>
<fig id="F9" position="float">
<label>FIGURE 9</label>
<caption>
<p>Effects of different doses of BGE on the p38/MAPK signaling pathway. <bold>(A)</bold> The expression of p-38, p-p38, p-MK2, and TTP obtained from ankle joints of several groups was detected by western blot analysis. <bold>(B)</bold> Quantitative analysis of gray value of p38 was performed in several groups with &#x3b2;-actin as loading control. <bold>(C)</bold> Quantitative analysis of gray value of p-p38 was performed in several groups with &#x3b2;-actin as loading control. <bold>(D)</bold> Quantitative analysis of gray value of p-MK2 was performed in several groups with &#x3b2;-actin as loading control. <bold>(E)</bold> Quantitative analysis of gray value of TTP was performed in several groups with &#x3b2;-actin as loading control. Data represent the mean &#xb1; S.E.M. of three independent experiments. <italic>p</italic> &#x3c; 0.05, <sup>&#x23;&#x23;</sup>
<italic>p</italic> &#x3c; 0.01 vs. Normal group; <sup>&#x2a;&#x2a;</sup>
<italic>p</italic> &#x3c; 0.01 vs. CFA group.</p>
</caption>
<graphic xlink:href="fphar-13-869810-g009.tif"/>
</fig>
</sec>
</sec>
<sec id="s4">
<title>4 Discussion</title>
<p>The etiology and pathogenesis of RA have not been clearly elucidated. The number of macrophages is one of the main factors in RA because the severity of the disease and the degree of joint damage are significantly related to the number of macrophages (<xref ref-type="bibr" rid="B17">Kinne et al., 2007</xref>). When macrophages are stimulated by LPS, they will activate MAPK and other related signal pathways, and then secrete a large number of inflammatory factors, such as TNF-&#x3b1;, IL-6, IL-1&#x3b2;, and PGE<sub>2</sub> (<xref ref-type="bibr" rid="B53">Xu et al., 2017</xref>; <xref ref-type="bibr" rid="B55">Yonezawa et al., 2018</xref>). RAW264.7 mouse macrophages are a type of macrophages. Because of their strong adhesion and ability to swallow antigens, they are generally used to build inflammation models and conduct research on inflammatory responses (<xref ref-type="bibr" rid="B2">Adams and Hamilton, 1984</xref>; <xref ref-type="bibr" rid="B54">Yang et al., 2014</xref>). LPS was used for stimulation to establish a macrophage inflammation model to study the effect of PEEP on inflammation and its molecular mechanism. According to the literature, the preliminary experimental results of the research group, 1&#xa0;&#x3bc;g/ml LPS was used to stimulate RAW264.7 macrophages to construct as vitro inflammation model. The CCK-8 method was used to detect the effects of different concentrations of <italic>P. aculeata</italic> Mill on the proliferation of RAW264.7 macrophages. The results showed that, the concentrations of PEEP (0, 15, 30, and 60&#xa0;&#x3bc;g/ml), EEEP (0, 5, 15, and 30&#xa0;&#x3bc;g/ml), and BEEP (0, 10, 20, and 40&#xa0;&#x3bc;g/ml) no significant effect on the survival rate of RAW264.7 macrophages when compared with the blank group. Therefore, PEEP (60&#xa0;&#x3bc;g/ml), EEEP (30&#xa0;&#x3bc;g/ml), and BEEP (40&#xa0;&#x3bc;g/ml) are selected as the highest concentrations for subsequent experiments.</p>
<p>In the early stage of inflammation, inflammatory cytokines such as TNF-&#x3b1; and IL-6 released by activated macrophages play an extremely important role in initiating local inflammation (<xref ref-type="bibr" rid="B46">Ueda et al., 2015</xref>). TNF-&#x3b1; is a potent pro-inflammatory cytokine released by macrophages, and its secretion reflect the severity of inflammation in the body (<xref ref-type="bibr" rid="B6">Caldwell et al., 1999</xref>; <xref ref-type="bibr" rid="B40">Su et al., 2015</xref>), and the excessive release of TNF-&#x3b1; can induce the production of other cytokines (such as IL-6), to further amplify the damage and destruction of TNF-&#x3b1; to inflamed tissues. Therefore, inhibiting the expression of TNF-&#x3b1; has a good control effect on the inflammatory response (<xref ref-type="bibr" rid="B14">Jayaraman et al., 2008</xref>). IL-6 plays an important role in chronic inflammatory diseases, and promotes the proliferation and differentiation of cells in inflammation (<xref ref-type="bibr" rid="B44">Tanaka and Kishimoto, 2014</xref>; <xref ref-type="bibr" rid="B41">Takeuchi et al., 2021</xref>). It is associated with high levels of IL-6 in a variety of inflammation-related diseases. Therefore, IL-6 is used as an indicator of anti-inflammatory efficacy (<xref ref-type="bibr" rid="B24">Mesquida et al., 2014</xref>). NO is a highly reactive oxidative free radical in organisms, which is generated by endogenous L-arginine under the catalysis of iNOS (<xref ref-type="bibr" rid="B32">Raij, 2006</xref>). It has been reported in the literature that NO is directly involved in the inflammatory response and joint damage process of RA (<xref ref-type="bibr" rid="B22">Mccartney-Francis et al., 2001</xref>). High expression levels of NO can cause hyperdilatation and increased exudation of blood, accompanied by the release of inflammatory cytokines (TNF-&#x3b1;, IL-6). TNF-&#x3b1; induces the synthesis of iNOS and further increases the level of NO (<xref ref-type="bibr" rid="B10">Cohen et al., 2017</xref>). Therefore, the level of NO can also be used as one of the important indicators for observing the inflammatory response. The NO colorimetric method to detect the effect of different concentrations of <italic>P. aculeata</italic> Mill extracts on the LPS-induced NO expression in RAW264.7 macrophages. The results show that the extracts from <italic>P. aculeata</italic> Mill significantly reduce NO. PEEP has the most significant effect which is dose-dependent. It is suggested that PEEP more effectively reduce the production of NO, and play a better therapeutic effect on intracellular inflammation and oxidative stress. Next, the Q-PCR experiment was conducted to investigate the effects of each extraction site of <italic>P. aculeata</italic> Mill on the expression of inflammatory factors in RAW264.7 macrophages induced by LPS. The results showed that PEEP significantly inhibit TNF-&#x3b1; and IL-6. EEEP and BEEP have no significant effect on the levels of TNF-&#x3b1; and IL-6 in cells. Based on the experimental results, PEEP significantly reduce the levels of NO, TNF-&#x3b1;, and IL-6 in activated RAW264.7 macrophage expression level and inhibit cell inflammatory response.</p>
<p>p38/MAPK is an important member of the MAPK family. It triggers a chain reaction of intracellular protein kinases under the stimulation of inflammatory factors and external factors, thereby affecting biological effects such as cell transcription, protein synthesis and cell surface receptor expression (<xref ref-type="bibr" rid="B26">Munoz and Ammit, 2010</xref>). The p38/MAPK signaling pathway is one of the most important family members that control inflammation, and plays an important role in the physiological and pathological processes such as inflammation, cell stress, apoptosis, cell cycle and growth (<xref ref-type="bibr" rid="B27">Niranjan et al., 2012</xref>). Under LPS stimulation, macrophages and the p38/MAPK signaling pathway be activated, and cause the secretion of a large number of inflammatory factors (TNF-&#x3b1;, IL-6) (<xref ref-type="bibr" rid="B57">Zhu et al., 2016</xref>; <xref ref-type="bibr" rid="B11">Dong et al., 2018</xref>). The activation of p38/MAPK lead to the overexpression of p-MK2 which downstream substrate of the pathway, and activated MK2 phosphorylate zinc finger protein 36 (Tristetraprolin, TTP), thereby over-promoting and regulating cytokines such as TNF-&#x3b1; and IL-6 hyperplasia leads to the continuous expression of inflammatory factors and causes a series of inflammatory reactions. Therefore, the p38-MK2-TTP axis mediate pro-inflammatory signals, which also explains why the knockout mouse MK2 gene cannot be successfully prepared into experimental arthritis (<xref ref-type="bibr" rid="B12">Hegen et al., 2006</xref>). We explored the effects of different concentrations of PEEP on the expression of p-p38, p-MK2 and TTP in RAW264.7 macrophags stimulated by LPS in order to further explore the molecular mechanism of PEEP inhibiting inflammation. Western blot was used to detect the effect of PEEP on the p38/MAPK signaling pathway of RAW264.7 macrophages stimulated by LPS. The results showed that the expression of p38 in activated RAW264.7 macrophages was not significantly different The levels of p-p38 and p-MK2 in the cells induced by LPS increased significantly when compared with the blank group. The expressions of p-p38 and p-MK2 in PEEP (30 and 60&#xa0;&#x3bc;g/ml) were lower than those in the model group. The expression of TTP in each PEEP administration group increased when compared with the model group. The results suggest that PEEP exerts anti-inflammatory effects by regulating the p38/MAPK signaling pathway. PEEP can reduce the expression of NO, TNF-&#x3b1;, and IL-6 in RAW264.7 macrophages induced by LPS. The mechanism may be through regulating the p38/MAPK signaling pathway, thereby inhibiting LPS-induced inflammatory response in RAW264.7 macrophages.</p>
<p>CFA-induced arthritis model is the basic method of the immune arthritis rat model. It is an inflammatory response mediated by immune complexes and its pathogenesis is mainly based on molecular simulation theory. Intradermal injection of CFA delays the body&#x2019;s absorption and causes continuous stimulation of the body to produce a secondary autoimmune response (<xref ref-type="bibr" rid="B35">Shakeel et al., 2021</xref>). The primary lesion of adjuvant arthritis model rats is an acute stress response, it will appear red and swollen joints and foot soles after sensitization. The secondary lesions appeared about 10&#xa0;days ago, which was an autoimmune reaction, generally manifested as the swelling of joints and plantar joints on the inflamed side and non-inflamed side after modeling. The rat adjuvant arthritis model established by CFA is a simple method, with high success rate and stable model after establishment. Its pathological process and laboratory indicators are similar to those of RA and it is an ideal model for screening and researching drugs for the treatment of RA (<xref ref-type="bibr" rid="B50">Wang et al., 2019</xref>). Therefore, we established an CFA-induced arthritis rat model in order to further verify the anti-RA effective part of <italic>P. aculeata</italic> Mill. The results of this experiment show that, rats in the model group were injected with CFA intracutaneously on the right hind foot plantar. The inflamed right paw of the rat began to swell within 5&#x2013;9&#xa0;h, and the swelling degree of the rat&#x2019;s foot gradually became swollen. It swelled again 14&#xa0;days after modeling, secondary lesions generally appear at about 11&#xa0;days after inflammation, and the swelling of the contralateral foot gradually increases to a peak. <italic>P. aculeata</italic> Mill petroleum ether had a significant inhibitory effect on the swelling of the left and right paws of arthritis after 10&#xa0;days of administration when compared with the model group.</p>
<p>RA mainly manifests as persistent joint and synovial inflammation, accompanied by bone and bone erosion, joint adhesion, pannus formation, and inflammatory cell infiltration (<xref ref-type="bibr" rid="B45">Turesson et al., 2003</xref>; <xref ref-type="bibr" rid="B19">Lee et al., 2012</xref>). HE staining and X-ray observation of rat foot and ankle joints showed that the synovial tissue of the model group was proliferated, inflammatory cells infiltrated, and pannus formed. X-rays showed that the soft tissues of the model group were swollen, the joint space was narrow, and the articular surface was blurred. PEEP significantly improve synovial hyperplasia, inflammatory cell infiltration and pannus formation in rat foot and ankle joint disease, reduce the swelling of soft tissue around the foot joint, and improve the bone surface erosion in rats and the degree of joint space stenosis after administration when compared with the model group.</p>
<p>The spleen is the body&#x2019;s immune organ and plays a very important role in the body&#x2019;s immune function (<xref ref-type="bibr" rid="B52">Xu et al., 2021</xref>). The results of this experiment showed that the spleen index of the model group increased. PEEP reduce the spleen index of CFA rats when compared with the model group. It shows that CFA rats have immune disorders and damaged immune organs. A certain dose of PEEP has a protective effect on the immune function of CFA rats.</p>
<p>In the process of inflammation in CFA rats, the release of inflammatory cytokines (TNF-&#x3b1;, IL-6, IL-8, etc.) played an important role in the occurrence and development of inflammation, the disintegration of articular cartilage matrix and bone destruction (<xref ref-type="bibr" rid="B34">Scott et al., 2010</xref>; <xref ref-type="bibr" rid="B49">Wang et al., 2017</xref>; <xref ref-type="bibr" rid="B47">Uttra et al., 2018</xref>). TNF-&#x3b1; is one of the earliest and most important inflammatory mediators in the process of inflammation. It can activate neutrophils and lymphocytes, increase the permeability of vascular endothelial cells, regulate the metabolic activity of other tissues and promote the synthesis and release of other cytokines (<xref ref-type="bibr" rid="B25">Moelants et al., 2013</xref>). PGE<sub>2</sub> is an important inflammatory mediator as a second messenger. The inflammatory response is closely related to the part PGE<sub>2</sub> expression level. Studies have shown that high concentrations of PGE<sub>2</sub> will dilate capillaries, increase vascular permeability, tissue congestion and edema, aggravate inflammation, and even produce collagenase, erode cartilage, and destroy bone (<xref ref-type="bibr" rid="B3">Akaogi et al., 2006</xref>; <xref ref-type="bibr" rid="B8">Chen et al., 2012</xref>). Further studies have found that PGE<sub>2</sub> induce the production of IL-6, and these cytokines usually interact with each other to form a network and jointly participate in the pathogenesis of RA (<xref ref-type="bibr" rid="B21">Matsuno et al., 2002</xref>; <xref ref-type="bibr" rid="B5">Axmann et al., 2009</xref>; <xref ref-type="bibr" rid="B42">Takeuchi et al., 2020</xref>). Therefore, it can help determine the improvement or deterioration of the inflammatory state in rats when studying the levels of TNF-&#x3b1;, IL-6, and PGE<sub>2</sub>. The results showed that the expression levels of inflammatory factors TNF-&#x3b1;, IL-6, and PGE<sub>2</sub> in the serum of the model group increased significantly. PEEP reduce the levels of inflammatory factors TNF-&#x3b1;, IL-6, and PGE<sub>2</sub> in the serum of rats when compared with the model group.</p>
<p>We explored the regulation of PEEP on the p38/MAPK signaling pathway by detecting the protein expressions of p38, p-p38, p-MK2, and TTP in the ankle joints. It preliminarily proves that PEEP regulate the p38/MAPK pathway by inhibiting the expression levels of p-p38 and p-MK2 and reduce the phosphorylation of TTP, and ultimately slow down the inflammatory response and the progression of RA disease.</p>
<p>Each group of PEEP can reduce the index of the spleen of the immune organ, significantly improve the synovial hyperplasia, inflammatory cell infiltration and pannus formation in the foot and ankle joint disease of rats, reduce the swelling of the soft tissue around the foot and ankle joint, and improve the bone of the foot and ankle joint in rats surface erosion and joint space stenosis alleviate various inflammations in rats with adjuvant arthritis. The mechanism of action is that PEEP downregulates the levels of TNF-&#x3b1;, IL-6, and PGE<sub>2</sub> in rat serum by regulating the p38/MAPK pathway, thereby alleviating the RA inflammation and damage.</p>
<p>The pharmacodynamic evaluation <italic>in vitro</italic> and <italic>in vivo</italic> strongly demonstrated that the <italic>P. aculeata</italic> Mill petroleum ether site is the active site for anti-rheumatoid arthritis. <italic>P. aculeata</italic> Mill petroleum ether site regulate the p38/MAPK pathway by inhibiting the expression levels of p-p38 and p-MK2 and reduce the phosphorylation of TTP, and further inhibit the secretion of NO, TNF-&#x3b1;, IL-6, and PGE<sub>2</sub> inflammatory cytokines, eventually slow down the inflammatory response and the progression of RA disease (<xref ref-type="fig" rid="F10">Figure 10</xref>).</p>
<fig id="F10" position="float">
<label>FIGURE 10</label>
<caption>
<p>Schematic diagram of the mechanism of action of PEEP <italic>in vivo</italic>.</p>
</caption>
<graphic xlink:href="fphar-13-869810-g010.tif"/>
</fig>
</sec>
</body>
<back>
<sec id="s5">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are included in the article/Supplementary Materials, further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec id="s6">
<title>Ethics Statement</title>
<p>The animal study was reviewed and approved by the Guilin Medical University Laboratory Animal Ethics Committee.</p>
</sec>
<sec id="s7">
<title>Author Contributions</title>
<p>YiC directed the experimental process and revised the manuscript. KL participated in the experimental process and revised the manuscript. YuC collected materials, performed experiments, and wrote the manuscript. YQ and SC gave design suggestions for the experiment. GG and YH participated in the experimental process. ZM gave constructive comments on the experiment.</p>
</sec>
<sec id="s8">
<title>Funding</title>
<p>This work was supported by the National Natural Science Foundation of China (Nos. 82160832, 81873030 and 81673628) and the Natural Science Foundation of Guangxi Zhuang Autonomous Region (Nos. 2017GXNSFAA198255 and 2018GXNSFBA138028) and Guangxi Key Laboratory of Brain and Cognitive Neuroscience Open Project Funding (No. GKLBCN-20180105-03) and the Fourth Training Plan for Thousands of Young and Mid-aged Mainstay Teachers in Guangxi Colleges and Universities and 2020 College Student Innovation and Entrepreneurship Project Training Plan (No. 202010601099) and 2022 Annual Scientific Research Project of Guangdong Provincial Administration of Traditional Chinese Medicine (No. 20222138).</p>
</sec>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11">
<title>Abbreviations</title>
<p>BEEP, N-butanol Extract of Pereskia aculeate Miller; CCK-8, Cell Counting Kit-8; DEX, Dexamethasone; DMSO, Dimethyls&#x3bc;Lfoxide; EEEP, Ethyl Acetate Extract of Pereskia aculeate Miller; ELISA, Enzyme linked immunosorbent assay; CFA, Complete Freund&#x2019;s adjuvant; IL-6, &#x3b2;interleukin-6; LPS, Lipopolysaccharide; NO, Nitric oxide; PBS, Phosphate buffer asline; PEEP, Petroleum Ether Extract of Pereskia aculeate Miller; PGE2, Prostaglandin E2; p38MAPK, p38 mitogen-activated protein kinase; RA, Rheumatoid arithritis; TNF-&#x3b1;, Tumor necrosis factor &#x3b1;; TTP, Tristetraprolin.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abbasi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mousavi</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Jamalzehi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Alimohammadi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bezvan</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Mohammadi</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Strategies toward Rheumatoid Arthritis Therapy; the Old and the New</article-title>. <source>J. Cel Physiol</source> <volume>234</volume>, <fpage>10018</fpage>&#x2013;<lpage>10031</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.27860</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adams</surname>
<given-names>D. O.</given-names>
</name>
<name>
<surname>Hamilton</surname>
<given-names>T. A.</given-names>
</name>
</person-group> (<year>1984</year>). <article-title>The Cell Biology of Macrophage Activation</article-title>. <source>Annu. Rev. Immunol.</source> <volume>2</volume>, <fpage>283</fpage>&#x2013;<lpage>318</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.iy.02.040184.001435</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akaogi</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Nozaki</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Satoh</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Role of PGE2 and EP Receptors in the Pathogenesis of Rheumatoid Arthritis and as a Novel Therapeutic Strategy</article-title>. <source>Endocr. Metab. Immune Disord. Drug Targets</source> <volume>6</volume>, <fpage>383</fpage>&#x2013;<lpage>394</lpage>. <pub-id pub-id-type="doi">10.2174/187153006779025711</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aletaha</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Funovits</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Smolen</surname>
<given-names>J. S.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Physical Disability in Rheumatoid Arthritis Is Associated with Cartilage Damage rather Than Bone Destruction</article-title>. <source>Ann. Rheum. Dis.</source> <volume>70</volume>, <fpage>733</fpage>&#x2013;<lpage>739</lpage>. <pub-id pub-id-type="doi">10.1136/ard.2010.138693</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Axmann</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>B&#xf6;hm</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kr&#xf6;nke</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Zwerina</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Smolen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Schett</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Inhibition of Interleukin-6 Receptor Directly Blocks Osteoclast Formation <italic>In Vitro</italic> and <italic>In Vivo</italic>
</article-title>. <source>Arthritis Rheum.</source> <volume>60</volume>, <fpage>2747</fpage>&#x2013;<lpage>2756</lpage>. <pub-id pub-id-type="doi">10.1002/art.24781</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caldwell</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Oelsner</surname>
<given-names>D. H.</given-names>
</name>
<name>
<surname>Iezzoni</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Hespenheide</surname>
<given-names>E. E.</given-names>
</name>
<name>
<surname>Battle</surname>
<given-names>E. H.</given-names>
</name>
<name>
<surname>Driscoll</surname>
<given-names>C. J.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Cryptogenic Cirrhosis: Clinical Characterization and Risk Factors for Underlying Disease</article-title>. <source>Hepatology</source> <volume>29</volume>, <fpage>664</fpage>&#x2013;<lpage>669</lpage>. <pub-id pub-id-type="doi">10.1002/hep.510290347</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Therapeutic Effects of TACI-Ig on Rats with Adjuvant-Induced Arthritis via Attenuating Inflammatory Responses</article-title>. <source>Rheumatology (Oxford)</source> <volume>50</volume>, <fpage>862</fpage>&#x2013;<lpage>870</lpage>. <pub-id pub-id-type="doi">10.1093/rheumatology/keq404</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>W. P.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y. L.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>P. F.</given-names>
</name>
<name>
<surname>Bao</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>L. D.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Morin Inhibits Interleukin-1&#x3b2;-Induced Nitric Oxide and Prostaglandin E2 Production in Human Chondrocytes</article-title>. <source>Int. Immunopharmacol</source> <volume>12</volume>, <fpage>447</fpage>&#x2013;<lpage>452</lpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2011.12.024</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Sohn</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bjeldanes</surname>
<given-names>L. F.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Anti-inflammatory Effects of Chicanine on Murine Macrophage by Down-Regulating LPS-Induced Inflammatory Cytokines in I&#x3ba;B&#x3b1;/MAPK/ERK Signaling Pathways</article-title>. <source>Eur. J. Pharmacol.</source> <volume>724</volume>, <fpage>168</fpage>&#x2013;<lpage>174</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2013.12.016</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cohen</surname>
<given-names>S. B.</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Mariette</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Curtis</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>E. B.</given-names>
</name>
<name>
<surname>Nash</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Long-term Safety of Tofacitinib for the Treatment of Rheumatoid Arthritis up to 8.5 Years: Integrated Analysis of Data from the Global Clinical Trials</article-title>. <source>Ann. Rheum. Dis.</source> <volume>76</volume>, <fpage>1253</fpage>&#x2013;<lpage>1262</lpage>. <pub-id pub-id-type="doi">10.1136/annrheumdis-2016-210457</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Cortisol Modulates Inflammatory Responses in LPS-Stimulated RAW264.7 Cells via the NF-&#x39a;b and MAPK Pathways</article-title>. <source>BMC Vet. Res.</source> <volume>14</volume>, <fpage>30</fpage>. <pub-id pub-id-type="doi">10.1186/s12917-018-1360-0</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hegen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gaestel</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nickerson-Nutter</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>L. L.</given-names>
</name>
<name>
<surname>Telliez</surname>
<given-names>J. B.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>MAPKAP Kinase 2-deficient Mice Are Resistant to Collagen-Induced Arthritis</article-title>. <source>J. Immunol.</source> <volume>177</volume>, <fpage>1913</fpage>&#x2013;<lpage>1917</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.177.3.1913</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jeong</surname>
<given-names>S. W.</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Ahn</surname>
<given-names>K. S.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>D. C.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Anti-inflammatory Effects of an Ethanolic Extract of Guava (Psidium Guajava L.) Leaves <italic>In Vitro</italic> and <italic>In Vivo</italic>
</article-title>. <source>J. Med. Food</source> <volume>17</volume>, <fpage>678</fpage>&#x2013;<lpage>685</lpage>. <pub-id pub-id-type="doi">10.1089/jmf.2013.2936</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jayaraman</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Paget</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>Y. S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Mayer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chaudhry</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>TNF-alpha-mediated Inflammation in Cerebral Aneurysms: a Potential Link to Growth and Rupture</article-title>. <source>Vasc. Health Risk Manag.</source> <volume>4</volume>, <fpage>805</fpage>&#x2013;<lpage>817</lpage>. <pub-id pub-id-type="doi">10.2147/vhrm.s2700</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kanno</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shouji</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tomizawa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hiura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Osanai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ujibe</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2006</year>). <article-title>Inhibitory Effect of Naringin on Lipopolysaccharide (LPS)-induced Endotoxin Shock in Mice and Nitric Oxide Production in RAW 264.7 Macrophages</article-title>. <source>Life Sci.</source> <volume>78</volume>, <fpage>673</fpage>&#x2013;<lpage>681</lpage>. <pub-id pub-id-type="doi">10.1016/j.lfs.2005.04.051</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kazama</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Uchida</surname>
<given-names>D. T.</given-names>
</name>
<name>
<surname>Canzi</surname>
<given-names>K. N.</given-names>
</name>
<name>
<surname>De Souza</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Crestani</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gasparotto</surname>
<given-names>A.</given-names>
<suffix>JR.</suffix>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Involvement of Arginine-Vasopressin in the Diuretic and Hypotensive Effects of Pereskia Grandifolia Haw. (Cactaceae)</article-title>. <source>J. Ethnopharmacol</source> <volume>144</volume>, <fpage>86</fpage>&#x2013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2012.08.034</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kinne</surname>
<given-names>R. W.</given-names>
</name>
<name>
<surname>Stuhlm&#xfc;ller</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Burmester</surname>
<given-names>G. R.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Cells of the Synovium in Rheumatoid Arthritis. Macrophages</article-title>. <source>Arthritis Res. Ther.</source> <volume>9</volume>, <fpage>224</fpage>. <pub-id pub-id-type="doi">10.1186/ar2333</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koller</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Cusnir</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Reversible Alopecia Areata: a Little Known Side Effect of Leflunomide</article-title>. <source>Clin. Rheumatol.</source> <volume>38</volume>, <fpage>2015</fpage>&#x2013;<lpage>2016</lpage>. <pub-id pub-id-type="doi">10.1007/s10067-019-04577-3</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>S. W.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>Y. B.</given-names>
</name>
<name>
<surname>Chae</surname>
<given-names>W. J.</given-names>
</name>
<name>
<surname>Morio</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Alleviation of Rheumatoid Arthritis by Cell-Transducible Methotrexate upon Transcutaneous Delivery</article-title>. <source>Biomaterials</source> <volume>33</volume>, <fpage>1563</fpage>&#x2013;<lpage>1572</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2011.10.079</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malmstr&#xf6;m</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Catrina</surname>
<given-names>A. I.</given-names>
</name>
<name>
<surname>Klareskog</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>The Immunopathogenesis of Seropositive Rheumatoid Arthritis: from Triggering to Targeting</article-title>. <source>Nat. Rev. Immunol.</source> <volume>17</volume>, <fpage>60</fpage>&#x2013;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1038/nri.2016.124</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matsuno</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yudoh</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Katayama</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Nakazawa</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Uzuki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sawai</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2002</year>). <article-title>The Role of TNF-Alpha in the Pathogenesis of Inflammation and Joint Destruction in Rheumatoid Arthritis (RA): a Study Using a Human RA/SCID Mouse Chimera</article-title>. <source>Rheumatology (Oxford)</source> <volume>41</volume>, <fpage>329</fpage>&#x2013;<lpage>337</lpage>. <pub-id pub-id-type="doi">10.1093/rheumatology/41.3.329</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mccartney-Francis</surname>
<given-names>N. L.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Mizel</surname>
<given-names>D. E.</given-names>
</name>
<name>
<surname>Wahl</surname>
<given-names>S. M.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Selective Inhibition of Inducible Nitric Oxide Synthase Exacerbates Erosive Joint Disease</article-title>. <source>J. Immunol.</source> <volume>166</volume>, <fpage>2734</fpage>&#x2013;<lpage>2740</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.166.4.2734</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mcinnes</surname>
<given-names>I. B.</given-names>
</name>
<name>
<surname>Schett</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>The Pathogenesis of Rheumatoid Arthritis</article-title>. <source>N. Engl. J. Med.</source> <volume>365</volume>, <fpage>2205</fpage>&#x2013;<lpage>2219</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMra1004965</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mesquida</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Leszczynska</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lloren&#xe7;</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Ad&#xe1;n</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Interleukin-6 Blockade in Ocular Inflammatory Diseases</article-title>. <source>Clin. Exp. Immunol.</source> <volume>176</volume>, <fpage>301</fpage>&#x2013;<lpage>309</lpage>. <pub-id pub-id-type="doi">10.1111/cei.12295</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moelants</surname>
<given-names>E. A.</given-names>
</name>
<name>
<surname>Mortier</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Van Damme</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Proost</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Regulation of TNF-&#x3b1; with a Focus on Rheumatoid Arthritis</article-title>. <source>Immunol. Cel Biol</source> <volume>91</volume>, <fpage>393</fpage>&#x2013;<lpage>401</lpage>. <pub-id pub-id-type="doi">10.1038/icb.2013.15</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Munoz</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ammit</surname>
<given-names>A. J.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Targeting P38 MAPK Pathway for the Treatment of Alzheimer&#x27;s Disease</article-title>. <source>Neuropharmacology</source> <volume>58</volume>, <fpage>561</fpage>&#x2013;<lpage>568</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2009.11.010</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niranjan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Nath</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Shukla</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Melatonin Attenuated Mediators of Neuroinflammation and Alpha-7 Nicotinic Acetylcholine Receptor mRNA Expression in Lipopolysaccharide (LPS) Stimulated Rat Astrocytoma Cells, C6</article-title>. <source>Free Radic. Res.</source> <volume>46</volume>, <fpage>1167</fpage>&#x2013;<lpage>1177</lpage>. <pub-id pub-id-type="doi">10.3109/10715762.2012.697626</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peng</surname>
<given-names>Z. J.</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Teng</surname>
<given-names>Y. F.</given-names>
</name>
<name>
<surname>Qiao</surname>
<given-names>Z. Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y. F.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>The Paw Swelling Effect of Pereskia Aculeate miller on Adjuvant Arthritisin Rats</article-title>. <source>Sci. Tech. Vis.</source> <volume>14</volume>, <fpage>124</fpage>&#x2013;<lpage>126</lpage>. <pub-id pub-id-type="doi">10.19694/j.cnki.issn2095-2457.2018.14.055</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinto</surname>
<given-names>N. C.</given-names>
</name>
<name>
<surname>Machado</surname>
<given-names>D. C.</given-names>
</name>
<name>
<surname>Da Silva</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Conegundes</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Gualberto</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Gameiro</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Pereskia Aculeata Miller Leaves Present <italic>In Vivo</italic> Topical Anti-inflammatory Activity in Models of Acute and Chronic Dermatitis</article-title>. <source>J. Ethnopharmacol</source> <volume>173</volume>, <fpage>330</fpage>&#x2013;<lpage>337</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2015.07.032</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinto</surname>
<given-names>N. C.</given-names>
</name>
<name>
<surname>Scio</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>The Biological Activities and Chemical Composition of Pereskia Species (Cactaceae)-Aa Review</article-title>. <source>Plant Foods Hum. Nutr.</source> <volume>69</volume>, <fpage>189</fpage>&#x2013;<lpage>195</lpage>. <pub-id pub-id-type="doi">10.1007/s11130-014-0423-z</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>F. F.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X. Q.</given-names>
</name>
<name>
<surname>Shu</surname>
<given-names>Z. H.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Y. P.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Matrine Exerts a Strong Anti-arthritic Effect on Type II Collagen-Induced Arthritis in Rats by Inhibiting Inflammatory Responses</article-title>. <source>Int. J. Mol. Sci.</source> <volume>17</volume>, <fpage>410</fpage>. <pub-id pub-id-type="doi">10.3390/ijms17091410</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raij</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Nitric Oxide in the Pathogenesis of Cardiac Disease</article-title>. <source>J. Clin. Hypertens. (Greenwich)</source> <volume>8</volume>, <fpage>30</fpage>&#x2013;<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1111/j.1524-6175.2006.06025.x</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roussel</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Houle</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>B&#xe9;rub&#xe9;</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Olivenstein</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>IL-17 Promotes P38 MAPK-dependent Endothelial Activation Enhancing Neutrophil Recruitment to Sites of Inflammation</article-title>. <source>J. Immunol.</source> <volume>184</volume>, <fpage>4531</fpage>&#x2013;<lpage>4537</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.0903162</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scott</surname>
<given-names>D. L.</given-names>
</name>
<name>
<surname>Wolfe</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Huizinga</surname>
<given-names>T. W.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Rheumatoid Arthritis</article-title>. <source>Lancet</source> <volume>376</volume>, <fpage>1094</fpage>&#x2013;<lpage>1108</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(10)60826-4</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shakeel</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Alam</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Alqarni</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Alshetaili</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ghoneim</surname>
<given-names>M. M.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Investigating Antiarthritic Potential of Nanostructured Clove Oil (Syzygium Aromaticum) in CFA-Induced Arthritic Rats: Pharmaceutical Action and Delivery Strategies</article-title>. <source>Molecules</source> <volume>26</volume>, <fpage>7327</fpage>. <pub-id pub-id-type="doi">10.3390/molecules26237327</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shams</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Martinez</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Dawson</surname>
<given-names>J. R. D.</given-names>
</name>
<name>
<surname>Flores</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gabriel</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Garcia</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions</article-title>. <source>Front. Pharmacol.</source> <volume>12</volume>, <fpage>680043</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2021.680043</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>CD70-mediated CD27 Expression Downregulation Contributed to the Regulatory B10 Cell Impairment in Rheumatoid Arthritis</article-title>. <source>Mol. Immunol.</source> <volume>119</volume>, <fpage>92</fpage>&#x2013;<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1016/j.molimm.2020.01.016</pub-id> </citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Souza</surname>
<given-names>L. F.</given-names>
</name>
<name>
<surname>De Barros</surname>
<given-names>I. B.</given-names>
</name>
<name>
<surname>Mancini</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>De Martino</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Scandolera</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>De Feo</surname>
<given-names>V.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Chemical Composition and Biological Activities of the Essential Oils from Two Pereskia Species Grown in Brazil</article-title>. <source>Nat. Prod. Commun.</source> <volume>9</volume>, <fpage>1805</fpage>&#x2013;<lpage>1808</lpage>. <pub-id pub-id-type="doi">10.1177/1934578x1400901237</pub-id> </citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sparks</surname>
<given-names>J. A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Rheumatoid Arthritis</article-title>. <source>Ann. Intern. Med.</source> <volume>170</volume>, <fpage>ITC1</fpage>&#x2013;<lpage>ITC16</lpage>. <pub-id pub-id-type="doi">10.7326/AITC201901010</pub-id> </citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Su</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Giannopoulou</surname>
<given-names>E. G.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Interferon-&#x3b3; Regulates Cellular Metabolism and mRNA Translation to Potentiate Macrophage Activation</article-title>. <source>Nat. Immunol.</source> <volume>16</volume>, <fpage>838</fpage>&#x2013;<lpage>849</lpage>. <pub-id pub-id-type="doi">10.1038/ni.3205</pub-id> </citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takeuchi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Role of Interleukin-6 in Bone Destruction and Bone Repair in Rheumatoid Arthritis</article-title>. <source>Autoimmun. Rev.</source> <volume>20</volume>, <fpage>102884</fpage>. <pub-id pub-id-type="doi">10.1016/j.autrev.2021.102884</pub-id> </citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takeuchi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hirota</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sakaguchi</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Impaired T Cell Receptor Signaling and Development of T Cell-Mediated Autoimmune Arthritis</article-title>. <source>Immunol. Rev.</source> <volume>294</volume>, <fpage>164</fpage>&#x2013;<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1111/imr.12841</pub-id> </citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Sulaiman</surname>
<given-names>S. F.</given-names>
</name>
<name>
<surname>Najimuddin</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Samian</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Muhammad</surname>
<given-names>T. S.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Methanolic Extract of Pereskia Bleo (Kunth) DC. (Cactaceae) Induces Apoptosis in Breast Carcinoma, T47-D Cell Line</article-title>. <source>J. Ethnopharmacol</source> <volume>96</volume>, <fpage>287</fpage>&#x2013;<lpage>294</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2004.09.025</pub-id> </citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tanaka</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kishimoto</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>The Biology and Medical Implications of Interleukin-6</article-title>. <source>Cancer Immunol. Res.</source> <volume>2</volume>, <fpage>288</fpage>&#x2013;<lpage>294</lpage>. <pub-id pub-id-type="doi">10.1158/2326-6066.CIR-14-0022</pub-id> </citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turesson</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>O&#x27;Fallon</surname>
<given-names>W. M.</given-names>
</name>
<name>
<surname>Crowson</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Gabriel</surname>
<given-names>S. E.</given-names>
</name>
<name>
<surname>Matteson</surname>
<given-names>E. L.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Extra-articular Disease Manifestations in Rheumatoid Arthritis: Incidence Trends and Risk Factors over 46 Years</article-title>. <source>Ann. Rheum. Dis.</source> <volume>62</volume>, <fpage>722</fpage>&#x2013;<lpage>727</lpage>. <pub-id pub-id-type="doi">10.1136/ard.62.8.722</pub-id> </citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ueda</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Iizuka</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tago</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Narukawa</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kiuchi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kasahara</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Nepetaefuran and Leonotinin Isolated from Leonotis Nepetaefolia R. Br. Potently Inhibit the LPS Signaling Pathway by Suppressing the Transactivation of NF-&#x39a;b</article-title>. <source>Int. Immunopharmacol</source> <volume>28</volume>, <fpage>967</fpage>&#x2013;<lpage>976</lpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2015.08.015</pub-id> </citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uttra</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>AlamgeerSHAHZAD</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shahzad</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shabbir</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jahan</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Ephedra Gerardiana Aqueous Ethanolic Extract and Fractions Attenuate Freund Complete Adjuvant Induced Arthritis in Sprague Dawley Rats by Downregulating PGE2, COX2, IL-1&#x3b2;, IL-6, TNF-&#x3b1;, NF-kB and Upregulating IL-4 and IL-10</article-title>. <source>J. Ethnopharmacol</source> <volume>224</volume>, <fpage>482</fpage>&#x2013;<lpage>496</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2018.06.018</pub-id> </citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van der Woude</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>van der Helm-van Mil</surname>
<given-names>A. H. M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Update on the Epidemiology, Risk Factors, and Disease Outcomes of Rheumatoid Arthritis</article-title>. <source>Best Pract. Res. Clin. Rheumatol.</source> <volume>32</volume>, <fpage>174</fpage>&#x2013;<lpage>187</lpage>. <pub-id pub-id-type="doi">10.1016/j.berh.2018.10.005</pub-id> </citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C. F.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>C. R.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C. Z.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>C. S.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Anti-arthritic Effect of Berberine on Adjuvant-Induced Rheumatoid Arthritis in Rats</article-title>. <source>Biomed. Pharmacother.</source> <volume>89</volume>, <fpage>887</fpage>&#x2013;<lpage>893</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2017.02.099</pub-id> </citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Distributive differences of P2Xs between the forelimb and hind limb of adjuvant arthritis rats and intervention by Notopterygh rhizoma et radix</article-title>. <source>Pharm. Biol.</source> <volume>57</volume>, <fpage>82</fpage>&#x2013;<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1080/13880209.2018.1561730</pub-id> </citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xing</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Autoantibodies against Interleukin-21 Correlate with Disease Activity in Patients with Rheumatoid Arthritis</article-title>. <source>Clin. Rheumatol.</source> <volume>37</volume>, <fpage>75</fpage>&#x2013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1007/s10067-017-3862-8</pub-id> </citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Molecular Mechanism of the Regulatory Effect of Schisandrol A on the Immune Function of Mice Based on a Transcription Factor Regulatory Network</article-title>. <source>Front. Pharmacol.</source> <volume>12</volume>, <fpage>785353</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2021.785353</pub-id> </citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Aisa</surname>
<given-names>H. A.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Anti-inflammatory Effect of Pomegranate Flower in Lipopolysaccharide (LPS)-stimulated RAW264.7 Macrophages</article-title>. <source>Pharm. Biol.</source> <volume>55</volume>, <fpage>2095</fpage>&#x2013;<lpage>2101</lpage>. <pub-id pub-id-type="doi">10.1080/13880209.2017.1357737</pub-id> </citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Resveratrol Reduces the Proinflammatory Effects and Lipopolysaccharide- Induced Expression of HMGB1 and TLR4 in RAW264.7 Cells</article-title>. <source>Cell Physiol Biochem</source> <volume>33</volume>, <fpage>1283</fpage>&#x2013;<lpage>1292</lpage>. <pub-id pub-id-type="doi">10.1159/000358696</pub-id> </citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yonezawa</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Miyashita</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nejishima</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Takeda</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Imai</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ogawa</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Anti-inflammatory Effects of Olive-Derived Hydroxytyrosol on Lipopolysaccharide-Induced Inflammation in RAW264.7 Cells</article-title>. <source>J. Vet. Med. Sci.</source> <volume>80</volume>, <fpage>1801</fpage>&#x2013;<lpage>1807</lpage>. <pub-id pub-id-type="doi">10.1292/jvms.18-0250</pub-id> </citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname>
<given-names>H. Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X. L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X. H.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>J. F.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Analysis of Patents on Anti-rheumatoid Arthritis Therapies Issued in China</article-title>. <source>Expert Opin. Ther. Pat</source> <volume>25</volume>, <fpage>909</fpage>&#x2013;<lpage>930</lpage>. <pub-id pub-id-type="doi">10.1517/13543776.2015.1044972</pub-id> </citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tu</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>GYF-17, a Chloride Substituted 2-(2-Phenethyl)-Chromone, Suppresses LPS-Induced Inflammatory Mediator Production in RAW264.7 Cells by Inhibiting STAT1/3 and ERK1/2 Signaling Pathways</article-title>. <source>Int. Immunopharmacol</source> <volume>35</volume>, <fpage>185</fpage>&#x2013;<lpage>192</lpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2016.03.044</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>